HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening

Human immunodeficiency virus type-1 (HIV-1) infection causes acquired immunodeficiency syndrome (AIDS). Currently, several anti-retroviral drugs are available, but adverse effects of these drugs have been reported. Herein, we focused on the anti-HIV-1 activity of <i>Curcuma aeruginosa</i>...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chanin Sillapachaiyaporn, Panthakarn Rangsinth, Sunita Nilkhet, Nuntanat Moungkote, Siriporn Chuchawankul
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/868825416cb14bffa4f2f4ba30a4ba17
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:868825416cb14bffa4f2f4ba30a4ba17
record_format dspace
spelling oai:doaj.org-article:868825416cb14bffa4f2f4ba30a4ba172021-11-25T18:39:28ZHIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening10.3390/ph141111151424-8247https://doaj.org/article/868825416cb14bffa4f2f4ba30a4ba172021-10-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1115https://doaj.org/toc/1424-8247Human immunodeficiency virus type-1 (HIV-1) infection causes acquired immunodeficiency syndrome (AIDS). Currently, several anti-retroviral drugs are available, but adverse effects of these drugs have been reported. Herein, we focused on the anti-HIV-1 activity of <i>Curcuma aeruginosa</i> Roxb. (CA) extracted by hexane (CA-H), ethyl acetate (CA-EA), and methanol (CA-M). The in vitro HIV-1 protease (PR) and HIV-1 reverse transcriptase (RT) inhibitory activities of CA extracts were screened. CA-M potentially inhibited HIV-1 PR (82.44%) comparable to Pepstatin A (81.48%), followed by CA-EA (67.05%) and CA-H (47.6%), respectively. All extracts exhibited moderate inhibition of HIV-1 RT (64.97 to 76.93%). Besides, phytochemical constituents of CA extracts were identified by GC-MS and UPLC-HRMS. Fatty acids, amino acids, and terpenoids were the major compounds found in the extracts. Furthermore, drug-likeness parameters and the ability of CA-identified compounds on blocking of the HIV-1 PR and RT active sites were in silico investigated. Dihydroergocornine, 3β,6α,7α-trihydroxy-5β-cholan-24-oic acid, and 6β,11β,16α,17α,21-Pentahydroxypregna-1,4-diene-3,20-dione-16,17-acetonide showed strong binding affinities at the active residues of both HIV-1 PR and RT. Moreover, antioxidant activity of CA extracts was determined. CA-EA exhibited the highest antioxidant activity, which positively related to the amount of total phenolic content. This study provided beneficial data for anti-HIV-1 drug discovery from CA extracts.Chanin SillapachaiyapornPanthakarn RangsinthSunita NilkhetNuntanat MoungkoteSiriporn ChuchawankulMDPI AGarticle<i>Curcuma aeruginosa</i> Roxb.HIV-1 protease inhibitorHIV-1 reverse transcriptase inhibitorimmunodeficiency virusAIDSvirtual screeningMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1115, p 1115 (2021)
institution DOAJ
collection DOAJ
language EN
topic <i>Curcuma aeruginosa</i> Roxb.
HIV-1 protease inhibitor
HIV-1 reverse transcriptase inhibitor
immunodeficiency virus
AIDS
virtual screening
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle <i>Curcuma aeruginosa</i> Roxb.
HIV-1 protease inhibitor
HIV-1 reverse transcriptase inhibitor
immunodeficiency virus
AIDS
virtual screening
Medicine
R
Pharmacy and materia medica
RS1-441
Chanin Sillapachaiyaporn
Panthakarn Rangsinth
Sunita Nilkhet
Nuntanat Moungkote
Siriporn Chuchawankul
HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
description Human immunodeficiency virus type-1 (HIV-1) infection causes acquired immunodeficiency syndrome (AIDS). Currently, several anti-retroviral drugs are available, but adverse effects of these drugs have been reported. Herein, we focused on the anti-HIV-1 activity of <i>Curcuma aeruginosa</i> Roxb. (CA) extracted by hexane (CA-H), ethyl acetate (CA-EA), and methanol (CA-M). The in vitro HIV-1 protease (PR) and HIV-1 reverse transcriptase (RT) inhibitory activities of CA extracts were screened. CA-M potentially inhibited HIV-1 PR (82.44%) comparable to Pepstatin A (81.48%), followed by CA-EA (67.05%) and CA-H (47.6%), respectively. All extracts exhibited moderate inhibition of HIV-1 RT (64.97 to 76.93%). Besides, phytochemical constituents of CA extracts were identified by GC-MS and UPLC-HRMS. Fatty acids, amino acids, and terpenoids were the major compounds found in the extracts. Furthermore, drug-likeness parameters and the ability of CA-identified compounds on blocking of the HIV-1 PR and RT active sites were in silico investigated. Dihydroergocornine, 3β,6α,7α-trihydroxy-5β-cholan-24-oic acid, and 6β,11β,16α,17α,21-Pentahydroxypregna-1,4-diene-3,20-dione-16,17-acetonide showed strong binding affinities at the active residues of both HIV-1 PR and RT. Moreover, antioxidant activity of CA extracts was determined. CA-EA exhibited the highest antioxidant activity, which positively related to the amount of total phenolic content. This study provided beneficial data for anti-HIV-1 drug discovery from CA extracts.
format article
author Chanin Sillapachaiyaporn
Panthakarn Rangsinth
Sunita Nilkhet
Nuntanat Moungkote
Siriporn Chuchawankul
author_facet Chanin Sillapachaiyaporn
Panthakarn Rangsinth
Sunita Nilkhet
Nuntanat Moungkote
Siriporn Chuchawankul
author_sort Chanin Sillapachaiyaporn
title HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
title_short HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
title_full HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
title_fullStr HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
title_full_unstemmed HIV-1 Protease and Reverse Transcriptase Inhibitory Activities of <i>Curcuma aeruginosa</i> Roxb. Rhizome Extracts and the Phytochemical Profile Analysis: In Vitro and In Silico Screening
title_sort hiv-1 protease and reverse transcriptase inhibitory activities of <i>curcuma aeruginosa</i> roxb. rhizome extracts and the phytochemical profile analysis: in vitro and in silico screening
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/868825416cb14bffa4f2f4ba30a4ba17
work_keys_str_mv AT chaninsillapachaiyaporn hiv1proteaseandreversetranscriptaseinhibitoryactivitiesoficurcumaaeruginosairoxbrhizomeextractsandthephytochemicalprofileanalysisinvitroandinsilicoscreening
AT panthakarnrangsinth hiv1proteaseandreversetranscriptaseinhibitoryactivitiesoficurcumaaeruginosairoxbrhizomeextractsandthephytochemicalprofileanalysisinvitroandinsilicoscreening
AT sunitanilkhet hiv1proteaseandreversetranscriptaseinhibitoryactivitiesoficurcumaaeruginosairoxbrhizomeextractsandthephytochemicalprofileanalysisinvitroandinsilicoscreening
AT nuntanatmoungkote hiv1proteaseandreversetranscriptaseinhibitoryactivitiesoficurcumaaeruginosairoxbrhizomeextractsandthephytochemicalprofileanalysisinvitroandinsilicoscreening
AT siripornchuchawankul hiv1proteaseandreversetranscriptaseinhibitoryactivitiesoficurcumaaeruginosairoxbrhizomeextractsandthephytochemicalprofileanalysisinvitroandinsilicoscreening
_version_ 1718410846299750400